APA (7th ed.) Citation

Vivekanandam, V., Jayaseelan, D., Skorupinska, Germain, L., Matthews, E., Barohn, R., . . . Hanna, M. (2024). 22O Mexiletine versus lamotrigine in non-dystrophic myotonias – a randomised, double-blinded, cross-over trial. Neuromuscular Disorders, 43, N.PAG. https://doi.org/10.1016/j.nmd.2024.07.746

Chicago Style (17th ed.) Citation

Vivekanandam, V., D. Jayaseelan, Skorupinska, L. Germain, E. Matthews, R. Barohn, M. McDermott, and M. Hanna. "22O Mexiletine Versus Lamotrigine in Non-dystrophic Myotonias – a Randomised, Double-blinded, Cross-over Trial." Neuromuscular Disorders 43 (2024): N.PAG. https://doi.org/10.1016/j.nmd.2024.07.746.

MLA (9th ed.) Citation

Vivekanandam, V., et al. "22O Mexiletine Versus Lamotrigine in Non-dystrophic Myotonias – a Randomised, Double-blinded, Cross-over Trial." Neuromuscular Disorders, vol. 43, 2024, p. N.PAG, https://doi.org/10.1016/j.nmd.2024.07.746.